retatrutide in the us Promises Big Weight Loss, but Safety Remains a Question Retatrutide Results: 28.3% Weight Loss

HHS has announced that GHK-Cu is expected to return to Category 1, which would restore compounding access for injectable formulations. BPC-157 On 23 July 2026, PCAC voted to recommend adding BPC-157 to the 503A Bulks List, in opposition to the FDA staff review, which had recommended against listing

384, 10 Feb

LG and XRHealth will continue to grow the service offering to deliver more insights to clinicians and enable more precise personalized care

DAC vs No DAC (This Matters More Than People Think) CJC-1295 comes in two forms: With DAC (Drug Affinity Complex) Binds to albumin in the blood Half-life: 68 days Dosing: once per week Creates a steady, elevated baseline Best for: Simplicity Consistent GH elevation Less frequent injections Without DAC Half-life: ~30 minutes Dosed alongside Ipamorelin Creates a more natural pulsatile release Best for: Mimicking natural rhythms More controlled GH spikes Key Takeaway: Neither is better. Your goal determines the version

Schedule an Appointment Online Submit Scheduling Form Submit Scheduling Form Fill out our scheduling form below